Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-19

Clinical Trial Update: A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain [Phase 4]

View source ↗

Summary

A Phase 4 study comparing morphine alone versus morphine plus dexmedetomidine in chronic cancer pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)
  • Precedex (dexmedetomidine) (dexmedetomidine)

Snippet

Sponsor: Cukurova University | Conditions: Chronic Pain | Phase 4 | Status: COMPLETED